Search

Danaher Corp

Deschisă

SectorSănătate

230.85 3.01

Rezumat

Modificarea prețului

24h

Curent

Minim

222.5

Maxim

227.71

Indicatori cheie

By Trading Economics

Venit

-159M

870M

Vânzări

314M

6.3B

P/E

Medie Sector

39.713

48.735

EPS

1.94

Randament dividend

0.66

Marjă de profit

13.887

Angajați

58,000

EBITDA

353M

1.8B

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+5.6% upside

Dividende

By Acuity

Randament dividend

Medie Sector

0.66%

2.24%

Următoarele câștiguri

21 oct. 2026

Data viitoare de dividende

30 oct. 2026

Următoarea dată ex-dividende

25 dec. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

13B

156B

Deschiderea anterioară

227.84

Închiderea anterioară

230.85

Danaher Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

13 oct. 2026, 23:01 UTC

Danaher Corp is trading modestly higher in after-market hours, maintaining a position well above its 20-day moving average despite notable fluctuations.

12 oct. 2026, 23:26 UTC

News

Danaher Corporation appoints Daniel L. Comas and Robert Hershberg, M.D., Ph.D., to its Board of Directors, expanding it from 11 to 13 members.

9 oct. 2026, 20:06 UTC

Correlated Moves

Danaher Corp shares are advancing, aligning with broader market gains and a rise in the life sciences sector, bolstered by positive developments at Repligen Corp.

8 oct. 2026, 23:01 UTC

Danaher Corp shares declined modestly in after-market hours, falling below Thursday's close amid unusual trading behavior and remaining in the middle of its one-month range.

7 oct. 2026, 23:00 UTC

Danaher Corp's shares traded lower in after-market hours, declining before slightly recovering, while remaining near the middle of their one-month trading range.

6 oct. 2026, 22:21 UTC

Danaher Corp's shares advanced modestly in after-market hours, reflecting broader market gains and positioning above its 20-day moving average.

5 oct. 2026, 23:15 UTC

Danaher Corp's shares are trading modestly lower in after-market hours, down from Monday's close despite a minor recovery earlier in the session.

2 oct. 2026, 20:03 UTC

Danaher Corp is advancing, continuing its upward trend since Thursday's close, despite pulling back from an earlier session high.

1 oct. 2026, 23:35 UTC

Danaher Corp is trading slightly lower in after-market hours, extending a trend of declines over the past four consecutive sessions.

30 sept. 2026, 23:00 UTC

Danaher Corp has advanced in after-market trading, moving significantly higher from a flat start and positioned well above its 20-day moving average.

29 sept. 2026, 20:21 UTC

Danaher Corp is trading modestly lower in after-market hours, declining after an initial uptick, despite being above its 20-day moving average.

28 sept. 2026, 23:01 UTC

Danaher Corp's shares are trading modestly lower in after-market hours, continuing a decline since Monday's close and remaining at their lowest point during this session.

26 sept. 2026, 00:01 UTC

Danaher Corp is declining in after-market trading, moving lower since Friday's close, ending a streak of five consecutive higher sessions.

25 sept. 2026, 20:12 UTC

Danaher Corp is trading modestly lower in after-market hours, maintaining a loss since Friday's close despite being above its 20-day moving average.

24 sept. 2026, 23:01 UTC

Danaher Corp is trading modestly lower in after-market hours, following a notable decline that resulted in a significantly negative cumulative return for the day.

23 sept. 2026, 22:36 UTC

Danaher Corp is lower in after-market trading, showing a slight recovery after a decline earlier in the session, remaining near its one-month range.

22 sept. 2026, 20:07 UTC

Social Media
News

Danaher Corp shares reached a four-week high today, marking the highest price since August 2026, supported by strong online commentary and strategic adjustments.

21 sept. 2026, 22:41 UTC

Danaher Corp's shares declined modestly in after-market trading, reversing an initial uptick, but remain above their 20-day moving average.

18 sept. 2026, 20:06 UTC

Correlated Moves

Danaher Corp shares fell modestly as the market trades lower, influenced by a slight decline in Thermo Fisher Scientific after an early high.

17 sept. 2026, 23:31 UTC

Danaher Corp is experiencing a modest rise in after-market trading, remaining above its 20-day moving average and near the upper end of its one-month range.

16 sept. 2026, 20:10 UTC

News
Correlated Moves

Danaher Corporation's shares are modestly lower despite the launch of research-grade S.p. Cas9 mRNA by its subsidiaries Integrated DNA Technologies and Aldevron.

15 sept. 2026, 23:01 UTC

Danaher Corp shares are lower in after-hours trading amid volatility. The New York Empire State Manufacturing Index fell sharply, impacting investor sentiment.

14 sept. 2026, 23:26 UTC

Danaher Corp shares are higher in after-market trading, reflecting a modest gain since Monday's close. The stock remains below its 20-day moving average.

11 sept. 2026, 20:08 UTC

News

Danaher Corp shares fell to a five-week low of 199.48 USD, marking six consecutive sessions of losses amid broader market declines.

10 sept. 2026, 23:31 UTC

Danaher Corp shares are higher in after-market trading, recovering from a session low. This follows four consecutive sessions of declines.

8 sept. 2026, 19:46 UTC

Danaher Corp shares are lower today, with no specific news driving the decline. Investors are focused on upcoming inflation data impacting Federal Reserve policy.

4 sept. 2026, 23:15 UTC

Danaher Corp shares are lower in after-market trading, declining since Friday's close amid rising Treasury yields and shifting interest rate expectations.

3 sept. 2026, 23:36 UTC

Danaher Corp shares are lower in after-market hours, declining from a brief recovery earlier in the session. No specific news was identified for the move.

2 sept. 2026, 20:08 UTC

Danaher Corp shares are higher Wednesday, reflecting a broader market gain since Tuesday. The stock peaked earlier before pulling back from session highs.

1 sept. 2026, 23:01 UTC

Danaher Corp shares are higher in after-market trading, reflecting modest gains since Tuesday's close. No specific news was identified to explain the movement.

Comparație

Modificare preț

Danaher Corp Așteptări

Obiectiv de preț

By TipRanks

5.6% sus

Prognoză pe 12 luni

Medie 235.313 USD  5.6%

Maxim 255 USD

Minim 200 USD

În baza a 17 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruDanaher Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

17 ratings

16

Cumpărare

1

Păstrare

0

Vânzare

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Danaher Corp

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company has a research collaboration with Stanford University's Department of Bioengineering for cancer drug development. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.
help-icon Live chat